A Multicenter Double-blind Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients ...

Printer-friendly versionSend by emailPDF version

Name

Polynoma, LLC

Anticipated Amount

272 825.00

Activity Type

Clinical Trial

Award Type

Contract

Date

May 8, 2012 to May 1, 2015

Award Number

005432-00001

Sponsor Award Number

POL-103A

Award Contacts

Name

Cranmer,Lee D

Title

Principal Investigator

Unit

Medicine

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona